Filing Flows › Comparisons › HRMY vs TGTX
Harmony Biosciences Holdings vs TG Therapeutics: HRMY and TGTX compared
Harmony Biosciences Holdings is the larger company: $269M of revenue in its latest quarter (Q3 2026) against $260M for TG Therapeutics (Q3 2026). TG Therapeutics is growing faster (+61% against +12% a year earlier). TG Therapeutics is more profitable, with an operating margin of 33.0% against 20.2%.
Where the money goes: HRMY and TGTX
Harmony Biosciences Holdings (HRMY) · Q3 2026
Harmony Biosciences Holdings, Q3 2026: revenue $269M (+12% year over year), operating margin 20.2%, net earnings $48.2M, operating cash flow $76.7M. The chart follows the revenue to costs, profit and cash.
TG Therapeutics (TGTX) · Q3 2026
TG Therapeutics, Q3 2026: revenue $260M (+61% year over year), operating margin 33.0%, net earnings $55.5M. The chart follows the revenue to costs, profit and cash.
| Harmony Biosciences Holdings (HRMY) | TG Therapeutics (TGTX) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $269M | $260M |
| Revenue growth, Y/Y | +12% | +61% |
| Gross margin | 70.0% | — |
| Operating margin | 20.2% | 33.0% |
| Net earnings | $48.2M | $55.5M |
| Net margin | 17.9% | 21.3% |
| Operating cash flow | $76.7M | — |
| Market value | — | $8.7B |
| P/E | — | 19.7× |
| Analysts’ mean target | — | $69.71 |
Where the revenue comes from
TG Therapeutics
- Product revenue, net: $240M (92%)
- License, milestone, royalty and other revenue: $19.9M (8%)
Questions
Which is bigger, Harmony Biosciences Holdings or TG Therapeutics?
Harmony Biosciences Holdings is the larger company: $269M of revenue in its latest quarter (Q3 2026) against $260M for TG Therapeutics (Q3 2026).
Is Harmony Biosciences Holdings or TG Therapeutics growing faster?
TG Therapeutics is growing faster (+61% against +12% a year earlier).
Which is more profitable, Harmony Biosciences Holdings or TG Therapeutics?
TG Therapeutics is more profitable, with an operating margin of 33.0% against 20.2%.
More: Harmony Biosciences Holdings earnings · how Harmony Biosciences Holdings makes money · TG Therapeutics earnings · how TG Therapeutics makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 4, 2026; 8-K filed Nov 9, 2026). Fiscal quarters can end on different dates. Not investment advice.